The types axis of the 3,5,6-Trichlorosalicylicacid market differentiates products by chemical form and functional modification, each influencing pricing and supply chain dynamics. The primary form, pure 3,5,6‑trichlorosalicylic acid, dominates the market, representing roughly 55 % of volume, as it is the preferred feedstock for bulk synthesis due to its high purity and established handling protocols. The sodium salt variant, accounting for about 25 %, offers enhanced solubility for aqueous formulations, making it attractive to pharmaceutical manufacturers and agrochemical formulators. Ester derivatives (e.g., methyl or ethyl esters) comprise 15 % of sales; their lower polarity facilitates incorporation into organic solvent‑based processes and specialty coatings. A niche hydroxy‑functionalized sub‑type, representing 5 %, is employed in advanced research settings where tailored reactivity is required for catalyst development. By segmenting the market into these product types, analysts can isolate cost drivers, assess raw‑material availability, and forecast shifts arising from regulatory or technological changes.